ARWR

ARWR

USD

Arrowhead Pharmaceuticals Inc. Common Stock

$37.850-0.750 (-1.943%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$38.600

Máximo

$39.310

Mínimo

$37.770

Volumen

1.40M

Fundamentos de la Empresa

Capitalización de Mercado

5.2B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

2.39M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $9.57Actual $37.850Máximo $43.69

Noticias Relacionadas

BusinessWire

Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming events: American Heart Association (AHA) Scientific Sessions 2025 – November 7-10,

Ver más
Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences
BusinessWire

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that as an inducement to entering into employment with the Company, on October 24, 2025, the Company's Board of Directors approved "inducement" grants to 84

Ver más
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BusinessWire

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that a global licensing and collaboration agreement with Novartis, previously announced on September 2, 2025, has now closed. Closing of the transaction was

Ver más
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.